AVITA Medical, Inc. (RCEL) Cost of Revenue USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
AVITA Medical, Inc. quarterly/annual Cost of Revenue history and growth rate from 2018 to 2024.
  • AVITA Medical, Inc. Cost of Revenue for the quarter ending March 31, 2024 was $1.51 M, a 9.24% decline year-over-year.
  • AVITA Medical, Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $7.63 M, a 28.6% increase year-over-year.
  • AVITA Medical, Inc. annual Cost of Revenue for 2023 was $7.78 M, a 28.8% increase from 2022.
  • AVITA Medical, Inc. annual Cost of Revenue for 2022 was $6.04 M, a 1.55% increase from 2021.
  • AVITA Medical, Inc. annual Cost of Revenue for 2021 was $5.95 M, a 100% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.63 M $1.51 M -$154 K -9.24% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $7.78 M $1.8 M +$449 K +33.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $7.33 M $2.11 M +$583 K +38.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.75 M $2.2 M +$818 K +59% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.93 M $1.67 M -$111 K -6.24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $6.04 M $1.35 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.53 M +$442 K +40.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.39 M -$667 K -32.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.78 M -$368 K -17.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $6.11 M $1.09 M +$159 K +17.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.95 M $2.05 M +$1.18 M +135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.77 M $2.15 M +$1.51 M +238% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.26 M $821 K -$25 K -2.96% Oct 1, 2020 Dec 31, 2020 10-K 2021-08-26
Q3 2020 $3.28 M $929 K +$310 K +50.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.97 M $874 K +$369 K +73.1% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-26
Q1 2020 $2.6 M $634 K +$342 K +117% Jan 1, 2020 Mar 31, 2020 10-K 2021-08-26
Q4 2019 $2.26 M $846 K +$604 K +250% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-26
Q3 2019 $1.66 M $619 K +$387 K +167% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-26
Q2 2019 $1.27 M $505 K Apr 1, 2019 Jun 30, 2019 10-K 2020-08-27
Q1 2019 $292 K Jan 1, 2019 Mar 31, 2019 10-K 2020-08-27
Q4 2018 $242 K Oct 1, 2018 Dec 31, 2018 10-K 2020-08-27
Q3 2018 $232 K Jul 1, 2018 Sep 30, 2018 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.